Literature DB >> 1880521

Allele frequencies of the third component of complement (C3) in MS patients.

D E Bulman1, H Armstrong, G C Ebers.   

Abstract

No difference was found in the allele frequency of C3 (third component of complement) in 129 multiple sclerosis (MS) patients compared with both 69 controls or with similar reported controls from the published literature. An association cannot be confirmed between C3 and MS.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1880521      PMCID： PMC488600          DOI： 10.1136/jnnp.54.6.554

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  11 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Buffer composition in paper electrophoresis; considerations on its influence, with special reference to the interaction between small ions and proteins.

Authors:  C B LAURELL; S LAURELL; N SKOOG
Journal:  Clin Chem       Date:  1956-04       Impact factor: 8.327

3.  A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex.

Authors:  E Seboun; M A Robinson; T H Doolittle; T A Ciulla; T J Kindt; S L Hauser
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

4.  A population-based study of multiple sclerosis in twins.

Authors:  G C Ebers; D E Bulman; A D Sadovnick; D W Paty; S Warren; W Hader; T J Murray; T P Seland; P Duquette; T Grey
Journal:  N Engl J Med       Date:  1986-12-25       Impact factor: 91.245

5.  Genetic polymorphism of C'3(beta1C-globulin) in human serum.

Authors:  E A Azen; O Smithies
Journal:  Science       Date:  1968-11-22       Impact factor: 47.728

6.  Association between C'3 phenotypes and various diseases.

Authors:  D D Farhud; R Ananthakrishnan; H Walter
Journal:  Humangenetik       Date:  1972

7.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.

Authors:  B G Weinshenker; B Bass; G P Rice; J Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1989-02       Impact factor: 13.501

8.  Genetic polymorphism of the third component of human complement (C'3).

Authors:  C A Alper; R P Propp
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

9.  Association between the C3F gene and atherosclerotic vascular diseases.

Authors:  H Sorensen; J Dissing
Journal:  Hum Hered       Date:  1975       Impact factor: 0.444

10.  Studies of a hypomorphic variant of human C3.

Authors:  C A Alper; F S Rosen
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808
View more
  1 in total

Review 1.  Complement in multiple sclerosis: its role in disease and potential as a biomarker.

Authors:  G Ingram; S Hakobyan; N P Robertson; B P Morgan
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.